Myocardial blood flow and contractile function are closely linked, but an ischemic insult can result in myocardial dysfunction (despite restoration of blood flow) in viable """"""""stunned"""""""" tissue that seems identical to nonviable infarcted tissue. Thus, myocardial dysfunction alone is insufficient to determine viability. In addition, conventional imaging techniques, which cannot resolve blood flow or function across the heart wall, often yield inaccurate viability classification due to volume averaging. Moreover, the lack of techniques to measure perfusion and function simultaneously has severely hindered the ability to determine the prevalence of stunned myocardium in patients. Cardiac magnetic resonance imaging (MRI), because of its high spatial resolution, is ideally suited to assess noninvasively both transmural myocardial function (using tagged MRI) and myocardial perfusion (using contrast- enhanced MRI). However, the potential to integrate MR parameters of myocardial function and perfusion to enhance the detection of stunned, ischemic, and infarcted tissue has not been exploited. Thus, the goal of this research is to determine the relationship between compromised myocardial perfusion and mechanical dysfunction through simultaneous measurement of perfusion and function using novel MRI techniques applied to canine ischemic models. More specifically, can these combined MRI measurements of perfusion and function be used to distinguish infarcted, ischemic, and stunned myocardium? Based on preliminary data we have obtained, combined MR indices of myocardial function and perfusion can enhance the identification of stunned myocardium. Thus, we will test whether: 1) Myocardial perfusion determined by contrast-enhanced MRI and myocardial function determined by tagged MRI, both individually and combined,, will enable the distinction of viable and nonviable tissue after ischemic insult that can be directly correlated to postmortem assessment and microsphere measurements of viability and blood flow, respectively; 2) Transmural differences in myocardial function and perfusion using MRI can be used to accurately classify tissue viability in clinical practice using conventional contrast agents and peripheral injections of contrast. The feasibility of this integrated MRI exam will be tested in animal models and in stable patients after myocardial infarction. Because the MRI techniques developed in these studies will be readily adaptable to clinical studies, the proposed research could have a significant impact on patient care in ischemic heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063439-04
Application #
6608794
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Dunn, Rosalie
Project Start
2000-07-15
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2005-06-30
Support Year
4
Fiscal Year
2003
Total Cost
$215,882
Indirect Cost
Name
Johns Hopkins University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Bulte, Jeff W M; Kostura, Lisa; Mackay, Alistair et al. (2005) Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model. Acad Radiol 12 Suppl 1:S2-6
Amado, Luciano C; Kraitchman, Dara L; Gerber, Bernhard L et al. (2004) Reduction of ""no-reflow"" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol 43:1291-8
Bulte, Jeff W M; Kraitchman, Dara L (2004) Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol 5:567-84
Amado, Luciano C; Gerber, Bernhard L; Gupta, Sandeep N et al. (2004) Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 44:2383-9
Azevedo, Clerio F; Amado, Luciano C; Kraitchman, Dara L et al. (2004) Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J 25:1419-27
Bulte, Jeff W M; Kraitchman, Dara L (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-99
Kostura, Lisa; Kraitchman, Dara L; Mackay, Alastair M et al. (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17:513-7
Karmarkar, P V; Kraitchman, D L; Izbudak, I et al. (2004) MR-trackable intramyocardial injection catheter. Magn Reson Med 51:1163-72
Kraitchman, Dara L; Heldman, Alan W; Atalar, Ergin et al. (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290-3
Kraitchman, Dara L; Sampath, Smita; Castillo, Ernesto et al. (2003) Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation 107:2025-30